hesperidin has been researched along with Cardiomegaly in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chakrapani, LN; Kalaiselvi, P; Kishore Kumar, SN; Mohan, T; Ravi, DB; Singh, A; Srinivasan, A; Varadharaj, S; Velusamy, P | 1 |
Arya, DS; Bhargava, P; Bhatia, J; Khan, SI; Malik, S; Verma, VK | 1 |
Bian, Z; Cheng, Z; Deng, W; Fang, Y; Jiang, D; Lin, Y; Liu, Y; Pu, P; Tang, Q; Zhang, J; Zhang, R; Zhou, H | 1 |
3 other study(ies) available for hesperidin and Cardiomegaly
Article | Year |
---|---|
Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis.
Topics: Animals; Antioxidants; Biomarkers; Cardiomegaly; Cell Line; Cell Nucleus; Cytoprotection; Gene Expression Regulation; Hesperidin; Homeostasis; Isoproterenol; Male; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Protein Transport; Rats, Wistar; RNA, Messenger; Signal Transduction; Superoxides | 2020 |
Hesperidin regresses cardiac hypertrophy by virtue of PPAR-γ agonistic, anti-inflammatory, antiapoptotic, and antioxidant properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cardiomegaly; Cardiotonic Agents; Gene Expression Regulation; Hesperidin; Isoproterenol; Male; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar | 2019 |
Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
Topics: Animals; Body Weight; Cardiomegaly; Cardiotonic Agents; Fibrosis; Gene Expression Regulation; Heart; Hesperidin; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Organ Size; Oxidative Stress; Protein Kinase C beta; Protein Kinase C-alpha; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Ventricular Pressure; Ventricular Remodeling | 2013 |